The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Cancer cachexia—pathophysiology and management
Open accessAbstract
About half of all cancer patients show a syndrome of cachexia, characterized by anorexia and loss of adipose tissue and skeletal muscle mass. Cachexia can have a profound impact on quality of life, symptom burden, and a patient's sense of dignity. It is a very serious complication, as weight loss during cancer treatment is associated with more chemotherapy-related side effects, fewer completed cycles of chemotherapy, and decreased survival rates. Numerous cytokines have been postulated to play a role in the etiology of cancer cachexia. Cytokines can elicit effects that mimic leptin signaling and suppress orexigenic ghrelin and neuropeptide Y (NPY) signaling, inducing sustained anorexia and cachexia not accompanied by the usual compensatory response. Furthermore, cytokines have been implicated in the induction of cancer-related muscle wasting. Cytokine-induced skeletal muscle wasting is probably a multifactorial process, which involves a protein synthesis inhibition, an increase in protein degradation, or a combination of both. The best treatment of the cachectic syndrome is a multifactorial approach. Many drugs including appetite stimulants, thalidomide, cytokine inhibitors, steroids, nonsteroidal anti-inflammatory drugs, branched-chain amino acids, eicosapentaenoic acid, and antiserotoninergic drugs have been proposed and used in clinical trials, while others are still under investigation using experimental animals. There is a growing awareness of the positive impact of supportive care measures and development of promising novel pharmaceutical agents for cachexia. While there has been great progress in understanding the underlying biological mechanisms of cachexia, health care providers must also recognize the psychosocial and biomedical impact cachexia can have.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, R. (1986) · Medical Entomology and Zoology · Cited by 8,752
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 2×
“C-reactive protein (CRP) is the most common method used to assess the magnitude of the systemic inflammatory response [36].”
BackgroundMethodCentral nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451
Definition and classification of cancer cachexia: an international consensus
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., Jatoi, A., Loprinzi, C., MacDonald, N., Mantovani, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70218-7 · Cited by 5,767
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Bodine, S. C., Stitt, T. N., Gonzalez, M., Kline, W. O., Stover, G. L., Bauerlein, R., Zlotchenko, E., Scrimgeour, A., Lawrence, J. C., Glass, D. J., et al. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1014 · Cited by 2,752
Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733
BODEY, G. P., BUCKLEY, M., SATHE, Y. S., & FREIREICH, E. J. (1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-328 · Cited by 2,469
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Physiology and immunology of the cholinergic antiinflammatory pathway
Tracey, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30555 · Cited by 1,563 · cited 1×
“Although the molecular mechanisms and cellular targets mediating ghrelin inhibition of NF-jB activation remain to be determined, the vagus nerve may play an important role in the ghrelin-mediated inhibition of proinflammatory cytokine release [150, 152].”
BackgroundInteracting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Kalra, S. P. (1999) · Endocrine Reviews · doi:10.1210/er.20.1.68 · Cited by 1,554
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight*
Kalra, S. P., Dube, M. G., Pu, S., Xu, B., Horvath, T. L., & Kalra, P. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0357 · Cited by 1,552
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Signals That Regulate Food Intake and Energy Homeostasis
Woods, S. C., Seeley, R. J., Porte, D., & Schwartz, M. W. (1998) · Science · doi:10.1126/science.280.5368.1378 · Cited by 1,169
15-Deoxy-Δ 12,14 -prostaglandin J 2 inhibits multiple steps in the NF-κB signaling pathway
Straus, D. S., Pascual, G., Li, M., Welch, J. S., Ricote, M., Hsiang, C.-H., Sengchanthalangsy, L. L., Ghosh, G., & Glass, C. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4844 · Cited by 1,004
Systemic inflammation, nutritional status and survival in patients with cancer
McMillan, D. C. (2009) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32832a7902 · Cited by 1,001
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974 · cited 1×
“influence this regulatory system [48, 50–52].”
Doyle, C., Kushi, L. H., Byers, T., Courneya, K. S., Demark-Wahnefried, W., Grant, B., McTiernan, A., Rock, C. L., Thompson, C., Gansler, T., et al. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.6.323 · Cited by 950
Cytokines and the nervous system II: actions and mechanisms of action
Rothwell, N. J., & Hopkins, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93890-a · Cited by 923
Dixit, V. D., Schaffer, E. M., Pyle, R. S., Collins, G. D., Sakthivel, S. K., Palaniappan, R., Lillard, J. W., & Taub, D. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421134 · Cited by 875
Ghrelin Strongly Stimulates Growth Hormone Release in Humans
Takaya, K., Ariyasu, H., Kanamoto, N., Iwakura, H., Yoshimoto, A., Harada, M., Mori, K., Komatsu, Y., Usui, T., Shimatsu, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7167 · Cited by 864 · cited 1×
“Ghrelin strongly stimulates GH secretion in humans [139–142] and does so more potently than GHRH by several fold under similar circumstances [143].”
BackgroundPasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Insulin in the Brain: A Hormonal Regulator of Energy Balance*
SCHWARTZ, M. W., FIGLEWICZ, D. P., BASKIN, D. G., WOODS, S. C., & PORTE, D. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-387 · Cited by 807
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., Chawla, S. P., Carides, A. D., Ianus, J., Elmer, M. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.095 · Cited by 779
Autophagy in metazoans: cell survival in the land of plenty
Lum, J. J., DeBerardinis, R. J., & Thompson, C. B. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1660 · Cited by 758
Cytokines and the nervous system I: expression and recognition
Hopkins, S. J., & Rothwell, N. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)80029-2 · Cited by 751
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice
Hein, L., Barsh, G. S., Pratt, R. E., Dzau, V. J., & Kobilka, B. K. (1995) · Nature · doi:10.1038/377744a0 · Cited by 742
Signalling pathways that mediate skeletal muscle hypertrophy and atrophy
Glass, D. J. (2003) · Nature Cell Biology · doi:10.1038/ncb0203-87 · Cited by 694
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., Aapro, M. S., Gandara, D., & Lindley, C. M. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.1.103 · Cited by 605
Fearon, K. C. H. (2003) · Gut · doi:10.1136/gut.52.10.1479 · Cited by 603
Cancer Anorexia-Cachexia Syndrome: Current Issues in Research and Management
Inui, A. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.2.72 · Cited by 579
Self-citationThe refeeding syndrome: a review
Solomon, S., & Kirby, D. (1990) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719001400190 · Cited by 561
Unraveling the central nervous system pathways underlying responses to leptin
Elmquist, J. K., Maratos-Flier, E., Saper, C. B., & Flier, J. S. (1998) · Nature Neuroscience · doi:10.1038/2164 · Cited by 520
Trikha, M., Corringham, R. E., Klein, B., & Rossi, J. (2003) · PubMed · Cited by 506
Arvat, E., Maccario, M., Di Vito, L., Broglio, F., Benso, A., Gottero, C., Papotti, M., Muccioli, G., Dieguez, C., Casanueva, F. F., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7314 · Cited by 503
Benefits of supplementary tube feeding after fractured neck of femur: a randomised controlled trial.
Bastow, M. D., Rawlings, J., & Allison, S. P. (1983) · BMJ · doi:10.1136/bmj.287.6405.1589 · Cited by 495
Li, W. G., Gavrila, D., Liu, X., Wang, L., Gunnlaugsson, S., Stoll, L. L., McCormick, M. L., Sigmund, C. D., Tang, C., & Weintraub, N. L. (2004) · Circulation · doi:10.1161/01.cir.0000127956.43874.f2 · Cited by 495
Lenk, K., Schuler, G., & Adams, V. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0007-1 · Cited by 494
Tisdale, M. J. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1763 · Cited by 487
McMillan, D. C. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108007131 · Cited by 472
Cancer cachexia: Developing multimodal therapy for a multidimensional problem
Fearon, K. C. H. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.033 · Cited by 444
Regulation of muscle mass by growth hormone and IGF‐I
Velloso, C. P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.153 · Cited by 442
Obesity and the Hypothalamus: Novel Peptides for New Pathways
Flier, J. S., & Maratos-Flier, E. (1998) · Cell · doi:10.1016/s0092-8674(00)80937-x · Cited by 430
Hypothalamic dopamine and serotonin in the regulation of food intake
Meguid, M. M., Fetissov, S. O., Varma, M., Sato, T., Zhang, L., Laviano, A., & Rossi-Fanelli, F. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00449-4 · Cited by 423
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ
LANGEN, R. C. J., SCHOLS, A. M. W. J., KELDERS, M. C. J. M., WOUTERS, E. F. M., & JANSSEN-HEININGER, Y. M. W. (2001) · The FASEB Journal · doi:10.1096/fj.00-0463 · Cited by 415
Falconer, J. S., Fearon, K. C. H., Plester, C. E., Ross, J. A., & Carter, D. C. (1994) · Annals of Surgery · doi:10.1097/00000658-199404000-00001 · Cited by 415
Eisenberg, P., Figueroa‐Vadillo, J., Zamora, R., Charu, V., Hajdenberg, J., Cartmell, A., Macciocchi, A., & Grunberg, S. (2003) · Cancer · doi:10.1002/cncr.11817 · Cited by 400
Ghrelin: An orexigenic and somatotrophic signal from the stomach
Inui, A. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086018 · Cited by 396
Self-citationImmunoregulators in the nervous system
Plata-Salamán, C. R. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80001-6 · Cited by 380
15-deoxy Δ^ -PGJ2 inhibits multiple steps in the NF-kappaB signaling pathway
Straus, D. S. (2000) · Medical Entomology and Zoology · Cited by 371
Neural-immune interactions in health and disease.
Sternberg, E. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119807 · Cited by 363
Arvat, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1169 · Cited by 357
The role of myostatin in muscle wasting: an overview
Elkina, Y., von Haehling, S., Anker, S. D., & Springer, J. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0035-5 · Cited by 348
Cancer anorexia-cachexia syndrome: are neuropeptides the key?
Inui, A. (1999) · PubMed · Cited by 342
Self-citationSystemic inflammation, cachexia and prognosis in patients with cancer
Deans, C., & Wigmore, S. J. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000165004.93707.88 · Cited by 331
Buck, M., & Chojkier, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00524.x · Cited by 326
The role of C-reactive protein as a prognostic indicator in advanced cancer
Mahmoud, F. A., & Rivera, N. I. (2002) · Current Oncology Reports · doi:10.1007/s11912-002-0023-1 · Cited by 325
Omran, M. L., & Morley, J. E. (2000) · Nutrition · doi:10.1016/s0899-9007(99)00224-5 · Cited by 318
Controlled Trial of Megestrol Acetate for the Treatment of Cancer Anorexia and Cachexia
Loprinzi, C. L., Ellison, N. M., Schaid, D. J., Krook, J. E., Athmann, L. M., Dose, A. M., Mailliard, J. A., Johnson, P. S., Ebbert, L. P., & Geeraerts, L. H. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.13.1127 · Cited by 318
Feeding and body-weight regulation by hypothalamic neuropeptides—mediation of the actions of leptin
Inui, A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01292-2 · Cited by 318
Self-citationTakeda, H., Sadakane, C., Hattori, T., Katsurada, T., Ohkawara, T., Nagai, K., & Asaka, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.078 · Cited by 311
Cytokines and the nervous system I: expression and recognition
HOPKINS, S. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93881-w · Cited by 306
Hataya, Y., Akamizu, T., Takaya, K., Kanamoto, N., Ariyasu, H., Saijo, M., Moriyama, K., Shimatsu, A., Kojima, M., Kangawa, K., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.8002 · Cited by 293 · cited 1×
“Furthermore, ghrelin and GHRH synergistically increases GH release [141].”
Background(2008) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10085 · Cited by 291
Amirouche, A., Durieux, A.-C., Banzet, S., Koulmann, N., Bonnefoy, R., Mouret, C., Bigard, X., Peinnequin, A., & Freyssenet, D. (2009) · Endocrinology · doi:10.1210/en.2008-0959 · Cited by 282
Cancer Cachexia: Mechanisms and Clinical Implications
Donohoe, C. L., Ryan, A. M., & Reynolds, J. V. (2011) · Gastroenterology Research and Practice · doi:10.1155/2011/601434 · Cited by 273
Central nervous system mechanisms contributing to the cachexia–anorexia syndrome
Plata-Salamán, C. R. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00413-5 · Cited by 271
Brink, M., Wellen, J., & Delafontaine, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118698 · Cited by 262
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Gonzalez–Rey, E., Chorny, A., & Delgado, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.041 · Cited by 259
Gélin, J., Moldawer, L. L., Lönnroth, C., Sherry, B. A., Chizzonite, R., & Lundholm, K. (1991) · PubMed · Cited by 251
Anorexia during acute and chronic disease
Plata-Salamán, C. R. (1996) · Nutrition · doi:10.1016/s0899-9007(96)90702-9 · Cited by 248
Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1
Musarò, A., Giacinti, C., Borsellino, G., Dobrowolny, G., Pelosi, L., Cairns, L., Ottolenghi, S., Cossu, G., Bernardi, G., Battistini, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0303792101 · Cited by 248
Waseem, T., Duxbury, M., Ito, H., Ashley, S. W., & Robinson, M. K. (2008) · Surgery · doi:10.1016/j.surg.2007.09.039 · Cited by 241
Myostatin Inhibits IGF-I-Induced Myotube Hypertrophy through Akt
Morissette, M. R., Cook, S. A., Buranasombati, C., Rosenberg, M. A., & Rosenzweig, A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00043.2009 · Cited by 231
Akamizu, T., Takaya, K., Irako, T., Hosoda, H., Teramukai, S., Matsuyama, A., Tada, H., Miura, K., Shimizu, A., Fukushima, M., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500447 · Cited by 231
Mantovani, G., Macciò, A., Madeddu, C., Serpe, R., Massa, E., Dessì, M., Panzone, F., & Contu, P. (2010) · The Oncologist · doi:10.1634/theoncologist.2009-0153 · Cited by 231
Body-composition changes in patients who gain weight while receiving megestrol acetate.
Loprinzi, C. L., Schaid, D. J., Dose, A. M., Burnham, N. L., & Jensen, M. D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.1.152 · Cited by 230
Benny Klimek, M. E., Aydogdu, T., Link, M. J., Pons, M., Koniaris, L. G., & Zimmers, T. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.123 · Cited by 229
Recent clinical experience with dronabinol
Plasse, T. F., Gorter, R. W., Krasnow, S. H., Lane, M., Shepard, K. V., & Wadleigh, R. G. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90385-f · Cited by 224
Loprinzi, C. L., Michalak, J. C., Schaid, D. J., Mailliard, J. A., Athmann, L. M., Goldberg, R. M., Tschetter, L. K., Hatfield, A. K., & Morton, R. F. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.4.762 · Cited by 223
Pathways and mechanisms for cytokine signaling of the central nervous system.
Licinio, J., & Wong, M. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119846 · Cited by 220 · cited 3×
“, ‘leaky’ areas in the BBB) [12–17].”
BackgroundNutritional Management in Long-Term Care: Development of a Clinical Guideline
Thomas, D. R., Ashmen, W., Morley, J. E., & Evans, W. J. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.12.m725 · Cited by 219
A World Health Organizadon Demonstration Project, Nelson, K., Walsh, D., Deeter, P., & Sheehan, F. (1994) · Journal of Palliative Care · doi:10.1177/082585979401000105 · Cited by 215
Anticachectin/tumor necrosis factor‐α antibodies attenuate development of cachexia in tumor models
Sherry, B. A., Gelin, J., Fong, Y., Marano, M., Wei, H., Cerami, A., Lowry, S. F., Lundholm, K. G., & Moldawer, L. L. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.8.2721856 · Cited by 207
Ghrelin Attenuates Sepsis-induced Acute Lung Injury and Mortality in Rats
Wu, R., Dong, W., Zhou, M., Zhang, F., Marini, C. P., Ravikumar, T. S., & Wang, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-511oc · Cited by 204
Matthys, P., & Billiau, A. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00185-8 · Cited by 201
Dimethylfumarate Inhibits TNF-Induced Nuclear Entry of NF-κB/p65 in Human Endothelial Cells
Loewe, R., Holnthoner, W., Gröger, M., Pillinger, M., Gruber, F., Mechtcheriakova, D., Hofer, E., Wolff, K., & Petzelbauer, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4781 · Cited by 197
Williams, A., Sun, X., Fischer, J. E., & Hasselgren, P.-O. (1999) · Surgery · doi:10.1016/s0039-6060(99)70131-5 · Cited by 196
Deans, D. A. C., Tan, B. H., Wigmore, S. J., Ross, J. A., de Beaux, A. C., Paterson-Brown, S., & Fearon, K. C. H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604828 · Cited by 191
UNGUREANULONGROIS, D., BALLIGAND, J., KELLY, R., & SMITH, T. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80015-6 · Cited by 188
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186
Effect of Branched-Chain Amino Acids on Muscle Atrophy in Cancer Cachexia
Eley, H. L., Russell, S. T., & Tisdale, M. J. (2007) · Biochemical Journal · doi:10.1042/bj20070651 · Cited by 184 · cited 1×
“Recent evidence suggests that PIF decreases protein synthesis by inhibiting protein translation initiation through phosphorylation of the eukaryotic initiation factor 2 (eIF2-alpha) [55].”
BackgroundŽdychová, J., & Komers, R. (2005) · Physiological Research · doi:10.33549/physiolres.930582 · Cited by 184
The Growth Hormone/Insulin-Like Growth Factor-I Axis in Exercise and Sport
Gibney, J., Healy, M.-L., & Sönksen, P. H. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0052 · Cited by 178
Hypothalamic response to starvation: implications for the study of wasting disorders
Schwartz, M. W., Dallman, M. F., & Woods, S. C. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.269.5.r949 · Cited by 177
Malnutrition in childhood cancer patients: A review on its prevalence and possible causes
Brinksma, A., Huizinga, G., Sulkers, E., Kamps, W., Roodbol, P., & Tissing, W. (2012) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.12.003 · Cited by 175
IGF-1 is downregulated in experimental cancer cachexia
Costelli, P., Muscaritoli, M., Bossola, M., Penna, F., Reffo, P., Bonetto, A., Busquets, S., Bonelli, G., Lopez-Soriano, F. J., Doglietto, G. B., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00104.2006 · Cited by 175
Transgenic Approach to the Study of Body Weight Regulation
Inui, A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01435-2 · Cited by 174
Self-citationHormone substitution in male hypogonadism
Zitzmann, M., & Nieschlag, E. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00227-0 · Cited by 169
Managing Cancer-Related Anorexia/Cachexia
Mantovani, G., Macci??, A., Massa, E., & Madeddu, C. (2001) · Drugs · doi:10.2165/00003495-200161040-00004 · Cited by 168
De Vry, J., & Schreiber, R. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00083-4 · Cited by 167
The MONA LISA hypothesis in the time of leptin.
Bray, G. A., & York, D. A. (1998) · PubMed · Cited by 164
Refeeding Syndrome: A Literature Review
Khan, L. U. R., Ahmed, J. B., Khan, S., & MacFie, J. (2010) · Gastroenterology Research and Practice · doi:10.1155/2011/410971 · Cited by 162
Herbal therapy use by cancer patients: A literature review on case reports
Olaku, O., & White, J. D. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.018 · Cited by 161
Serotonin Antagonists: A New Class of Antiemetic Agents
Hesketh, P. J., & Gandara, D. R. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.9.613 · Cited by 161
Couch, M. E., Lai, V., Cannon, T. Y., Guttridge, D. C., Zanation, A. M., George, J. R., Hayes, D. N., Zeisel, S. H., & Shores, C. G. (2007) · Head & Neck · doi:10.1002/hed.20447 · Cited by 159
Sullivan, D. H., Walls, R. C., & Bopp, M. M. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb06097.x · Cited by 158
Mantovani, G., Macciò, A., Lai, P., Massa, E., Ghiani, M., & Santona, M. C. (1998) · PubMed · Cited by 158
Both oxidative and nitrosative stress are associated with muscle wasting in tumour‐bearing rats
Barreiro, E., de la Puente, B., Busquets, S., López-Soriano, F. J., Gea, J., & Argilés, J. M. A. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.017 · Cited by 157
Potentiation of ghrelin signaling attenuates cancer anorexia–cachexia and prolongs survival
Fujitsuka, N., Asakawa, A., Uezono, Y., Minami, K., Yamaguchi, T., Niijima, A., Yada, T., Maejima, Y., Sedbazar, U., Sakai, T., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.25 · Cited by 154
Self-citationMegestrol acetate in cancer anorexia and weight loss
Tchekmedyian, N. S., Hickman, M., Siau, J., Greco, F. A., Keller, J. W., Browder, H. P., & Aisner, J. (1992) · Cancer · doi:10.1002/cncr.2820690532 · Cited by 153
Androgens in Postmenopausal Women: Production, Possible Role, and Replacement Options
Lobo, R. A. (2001) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200106000-00022 · Cited by 150
Signaling pathways weigh in on decisions to make or break skeletal muscle
Guttridge, D. C. (2004) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000134364.61406.26 · Cited by 149
Regulation of Central Melanocortin Signaling by Interleukin-1β
Scarlett, J. M., Jobst, E. E., Enriori, P. J., Bowe, D. D., Batra, A. K., Grant, W. F., Cowley, M. A., & Marks, D. L. (2007) · Endocrinology · doi:10.1210/en.2007-0017 · Cited by 147
Maltoni, M. C., Nanni, O., Scarpi, E., Rossi, D., Serra, P., & Amadori, D. (2001) · Annals of Oncology · doi:10.1023/a:1011156811739 · Cited by 147
Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise
Al‐Majid, S., & McCarthy, D. O. (2001) · Biological Research For Nursing · doi:10.1177/109980040100200304 · Cited by 146
de Wit, R., Herrstedt, J., Rapoport, B. L., Carides, A. D., Guoguang-Ma, J., Elmer, M. E., Schmidt, C., Evans, J. K., & Horgan, K. J. (2004) · PubMed · Cited by 144
Prognostic Factors in Advanced Gastrointestinal Cancer Patients With Weight Loss
O'Gorman, P., McMillan, D. C., & McArdle, C. S. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc3701_4 · Cited by 135
The role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies
Schwartz, S. A., Hernandez, A., & Mark Evers, B. (1999) · Surgical Oncology · doi:10.1016/s0960-7404(00)00012-8 · Cited by 132
Lorite, M. J., Smith, H. J., Arnold, J., Morris, A., Thompson, M., & Tisdale, M. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1879 · Cited by 132
Ros‐mediated activation of NF‐κB and Foxo during muscle disuse
Dodd, S. L., Gagnon, B. J., Senf, S. M., Hain, B. A., & Judge, A. R. (2010) · Muscle & Nerve · doi:10.1002/mus.21526 · Cited by 131
Mantovani, G., Macci�, A., Madeddu, C., Mura, L., Gramignano, G., Lusso, M. R., Massa, E., Mocci, M., & Serpe, R. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0476-1 · Cited by 126
Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice
Llovera, M., Garcia‐Martínez, C., López‐Soriano, J., Carbó, N., Agell, N., López-Soriano, F. J., & Argilés, J. M. A. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00105-1 · Cited by 120
Impact of Nutritional Status on Morbidity in a Population of Geriatric Rehabilitation Patients
Sullivan, D. H., & Walls, R. C. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb04966.x · Cited by 120
WOO, J., HO, S. C., MAK, Y. T., LAW, L. K., & CHEUNG, A. (1994) · Age and Ageing · doi:10.1093/ageing/23.1.40 · Cited by 118
Belizário, J. E., Lorite, M. J., & Tisdale, M. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1700 · Cited by 116
Cancer Cachexia: Traditional Therapies and Novel Molecular Mechanism-Based Approaches to Treatment
Kumar, N. B., Kazi, A., Smith, T., Crocker, T., Yu, D., Reich, R. R., Reddy, K. A., Hastings, S., Extermann, M., Balducci, L., et al. (2010) · Current Treatment Options in Oncology · doi:10.1007/s11864-010-0127-z · Cited by 114
C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Marsik, C. L., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., & Endler, G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091959 · Cited by 112
Antiemetic guidelines: creating a more practical treatment approach
Koeller, J. M., Aapro, M., Gralla, R. J., Grunberg, S. M., Hesketh, P. J., Kris, M. G., & Clark-Snow, R. A. (2002) · Supportive Care in Cancer · doi:10.1007/s00520-001-0335-y · Cited by 111
Reduced Ghrelin Secretion in the Hypothalamus of Rats due to Cisplatin-Induced Anorexia
Yakabi, K., Sadakane, C., Noguchi, M., Ohno, S., Ro, S., Chinen, K., Aoyama, T., Sakurada, T., Takabayashi, H., & Hattori, T. (2010) · Endocrinology · doi:10.1210/en.2010-0061 · Cited by 110
The Role of Cytokines in Cancer Cachexia
Moldawer, L. L., Rogy, M. A., & Lowry, S. F. (1992) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719201600602 · Cited by 109
The Role of Nutrition in Increased Morbidity and Mortality
Sullivan, D. H. (1995) · Clinics in Geriatric Medicine · doi:10.1016/s0749-0690(18)30264-7 · Cited by 105
Hypogonadism in male patients with cancer
Garcia, J. M., Li, H., Mann, D. L., Epner, D. E., Hayes, T. G., Marcelli, M., & Cunningham, G. R. (2006) · Cancer · doi:10.1002/cncr.21889 · Cited by 105
McCarthy, H. D., Crowder, R., Dryden, S. D., & Williams, G. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90229-1 · Cited by 105
Efficacy of Rikkunshito, a Traditional Japanese Medicine (Kampo), in Treating Functional Dyspepsia
Kusunoki, H., Haruma, K., Hata, J., Ishii, M., Kamada, T., Yamashita, N., Honda, K., Inoue, K., Imamura, H., Manabe, N., et al. (2010) · Internal Medicine · doi:10.2169/internalmedicine.49.3803 · Cited by 103
Barber, M. D., Ross, J. A., & Fearon, K. C. H. (1999) · Surgical Oncology · doi:10.1016/s0960-7404(99)00045-6 · Cited by 102
The Immunopharmaceutical Effects and Mechanisms of Herb Medicine
Huang, C.-F., Lin, S. C., Liao, P., Young, S.-C., & Yang, C. (2008) · Cellular and Molecular Immunology · doi:10.1038/cmi.2008.3 · Cited by 101
DNA Fragmentation Occurs in Skeletal Muscle during Tumor Growth: A Link with Cancer Cachexia?
van Royen, M. E., Carbó, N., Busquets, S., Alvarez, B., Quinn, L. S., López-Soriano, F. J., & Argilés, J. M. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2462 · Cited by 101
Cancer wasting and quality of life react to early individualized nutritional counselling!
Ravasco, P., Grillo, I. M., & Camilo, M. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.10.005 · Cited by 101
Akamizu, T., & Kangawa, K. (2010) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-010-0011-5 · Cited by 99
A Review of the Drug Treatment of Cachexia Associated with Cancer
Gagnon, B., & Bruera, E. D. (1998) · Drugs · doi:10.2165/00003495-199855050-00005 · Cited by 99
The cancer anorexia-cachexia syndrome.
Nelson, K. A. (2000) · PubMed · Cited by 98
de Wit, R., Herrstedt, J., Rapoport, B. L., Carides, A. D., Guoguang-Ma, J., Elmer, M. E., Schmidt, C., Evans, J. K., & Horgan, K. J. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.028 · Cited by 96
Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats
Torelli, G. F., Meguid, M. M., Moldawer, L. L., Edwards, C. K., Kim, H., Carter, J. L., Laviano, A., & Fanelli, F. R. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r850 · Cited by 92
Hypogonadism in male patients with metastatic cancer prior to chemotherapy.
Chlebowski, R. T., & Heber, D. (1982) · PubMed · Cited by 90
Cracking the riddle of cancer anorexia
Laviano, A., Meguid, M. M., Yang, Z., Gleason, J. R., Cangiano, C., & Fanelli, F. R. (1996) · Nutrition · doi:10.1016/s0899-9007(96)00164-5 · Cited by 85
Oxidative stress and wasting in cancer
Laviano, A., Meguid, M. M., Preziosa, I., & Fanelli, F. R. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328122db94 · Cited by 80
Cancer cachexia: A therapeutic approach
Argilés, J. M. A., Meijsing, S. H., Pallarés‐Trujillo, J., Guirao, X., & López-Soriano, F. J. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200101)21:1<83::aid-med4>3.0.co;2-1 · Cited by 78
Symptom Control in Palliative Care—Part II: Cachexia/Anorexia and Fatigue
Fabbro, E. D., Dalal, S., & Bruera, E. D. (2006) · Journal of Palliative Medicine · doi:10.1089/jpm.2006.9.409 · Cited by 76
Cachexia and Wasting: A Modern Approach
Mantovani, G., Yeh, S., Schuster, M. W., Scevola, D., Morley, J. E., Inui, A., Fanelli, F. R., & Anker, S. D. (2006) · Springer eBooks · doi:10.1007/978-88-470-0552-5 · Cited by 74
Self-citationAre cytokines possible mediators of cancer cachexia?
Noguchi, Y., Yoshikawa, T., Matsumoto, A., Svaninger, G., & Gelin, J. (1996) · Surgery today (Print) · doi:10.1007/bf00311551 · Cited by 73
Nagaya, N., Kojima, M., & Kangawa, K. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1402 · Cited by 72
Bonetto, A., Penna, F., Minero, V. G., Reffo, P., Bonelli, G., Baccino, F. M., & Costelli, P. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789057015 · Cited by 72
Primary care of the patient with cancer.
Smith, G. F., & Toonen, T. R. (2007) · PubMed · Cited by 68
Suppression of Experimental Autoimmune Encephalomyelitis by Ghrelin1
Theil, M., Miyake, S., Mizuno, M., Tomi, C., Croxford, J., Hosoda, H., Theil, J., von Hörsten, S., Yokote, H., Chiba, A., et al. (2009) · Journal of Immunology · doi:10.4049/jimmunol.0803362 · Cited by 68
Hematopoietic growth factors in the older cancer patient
Balducci, L., Hardy, C. L., & Lyman, G. H. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200105000-00008 · Cited by 60
Balasubramaniam, A., Joshi, R., Su, C., Friend, L. A., Sheriff, S., Kagan, R. J., & James, J. H. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00015.2008 · Cited by 59
Exercise, Cachexia, and Cancer Therapy: A Molecular Rationale
Ardies, C. M. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc422_1 · Cited by 57
Moertel, C. G., Kvols, L. K., & Rubin, J. (1991) · Cancer · Cited by 53
Cupoli, J. M., Hallock, J. A., & Barness, L. A. (1980) · Current Problems in Pediatrics · doi:10.1016/s0045-9380(80)80018-1 · Cited by 52
Garcia, J. M., Boccia, R. V., Graham, C., Kumor, K. M., & Polvino, W. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.9133 · Cited by 52
A Chart Review of Cyproheptadine for Stimulant-Induced Weight Loss
Daviss, W. B., & Scott, J. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454604773840508 · Cited by 51
Treatment of cachexia in oncology
Tazi, E. H., & Errihani, H. H. (2010) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.73644 · Cited by 50
Jenns, K. (1994) · Cancer Nursing · doi:10.1097/00002820-199412000-00006 · Cited by 42
Transgenic study of energy homeostasis equation: implications and confounding influences
Inui, A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0291rev · Cited by 40
Self-citationEating-related disorders in patients with advanced cancer
Strasser, F. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-002-0391-y · Cited by 38
Rikkunshi-to attenuates adverse gastrointestinal symptoms induced by fluvoxamine
Oka, T., Tamagawa, Y., Hayashida, S., et al. (2007) · BioPsychoSocial Medicine · doi:10.1186/1751-0759-1-21 · Cited by 34
Cachexia, Malnutrition, the Refeeding Syndrome, and Lessons from Goldilocks
Palesty, J. A., & Dudrick, S. J. (2011) · Surgical Clinics of North America · doi:10.1016/j.suc.2011.02.007 · Cited by 32
Effects of serotonin1/2 receptor agonists on dark-phase food and water intake in rats
Schreiber, R., Selbach, K., Asmussen, M., Hesse, D., & Vry, J. D. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00357-9 · Cited by 29
Costa, A. M., Spence, K. T., Plata‐Saláman, C. R., & ffrench-Mullen, J. M. H. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020880 · Cited by 29
Yamamoto, D., Ikeshita, N., Matsubara, T., Tasaki, H., Herningtyas, E. H., Toda, K., Iida, K., Takahashi, Y., Kaji, H., Chihara, K., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.11.019 · Cited by 28
Predictors of 2‐Year Mortality Among Older Male Veterans on a Geriatric Rehabilitation Unit
McMurtry, C. T., & Rosenthal, A. J. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb07012.x · Cited by 26
Sheriff, S., Joshi, R., Friend, L. A., James, J. H., & Balasubramaniam, A. (2009) · Peptides · doi:10.1016/j.peptides.2009.06.029 · Cited by 24
Anticancer drugs that induce cancer-associated cachectic syndromes
Tohgo, A., Kumazawa, E., Akahane, K., Asakawa, A., & Inui, A. (2002) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2.1.121 · Cited by 24
Self-citationLiu, Y., Hamaue, N., Endo, T., Hirafuji, M., & Minami, M. (2003) · PubMed · Cited by 20
Are All 5-HT3 Receptor Antagonists the Same?
McNulty, R. M. (2007) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2007.0005 · Cited by 19
Basics in Clinical Nutrition: Nutritional support in cancer
Bozzetti, F. (2009) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2009.06.018 · Cited by 17
Jolley, C. D. (2003) · Current problems in pediatric and adolescent health care · doi:10.1016/s1538-5442(03)00020-8 · Cited by 17
Genazzani, A. D., Strucchi, C., Malavasi, B., et al. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.4.279.285 · Cited by 11
The Current Management of Cancer Cachexia
Mantovani, G. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_54 · Cited by 4
Treatment of Cachexia in the Elderly
Yeh, S., & Schuster, M. W. (2007) · Springer eBooks · doi:10.1007/978-88-470-0552-5_68 · Cited by 2
The Biology of Cancer Cachexia and the Role of TNF-α
Guttridge, D. C. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-455-1_16 · Cited by 2
Lipton (1995) · Pure Amsterdam UMC · doi:10.1002/1097-0142(19950415)75:8 · Cited by 1
(1997) · doi:10.1002/(sici)1097-0142(19970501)79:9
Cited by
Cancer cachexia: understanding the molecular basis
Argilés, J. M., Busquets, S., Stemmler, B., & López-Soriano, F. J. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3829 · Cited by 1,517
Management of Cancer Cachexia: ASCO Guideline
Roeland, E. J., Bohlke, K., Baracos, V. E., Bruera, E., del Fabbro, E., Dixon, S., Fallon, M., Herrstedt, J., Lau, H., Platek, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00611 · Cited by 644
Thyroid Hormones, Oxidative Stress, and Inflammation
Mancini, A., Di Segni, C., Raimondo, S., Olivieri, G., Silvestrini, A., Meucci, E., & Currò, D. (2016) · Mediators of Inflammation · doi:10.1155/2016/6757154 · Cited by 529
Cancer Cachexia: Definition, Staging, and Emerging Treatments
Ni, J., & Zhang, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s261585 · Cited by 290
Shukla, S. K., Dasgupta, A., Mehla, K., Gunda, V., Vernucci, E., Souchek, J., Goode, G., King, R., Mishra, A., Rai, I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5843 · Cited by 96
Metadata
- Authors
- Suzuki, H., Asakawa, A., Amitani, H., Nakamura, N., & Inui, A.
- Venue
- Journal of Gastroenterology
- Published
- 2013-03-20
- Volume
- 48
- Issue
- 5
- Pages
- 574-594
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W1965087543
- Cited by
- 268
- References
- 193
- FWCI
- 13.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.